ANTIMYCOBACTERIAL ACTIVITY OF CRUDE EXTRACTS PRODUCED BY BACILLUS SP. ASSOCIATED WITH ENTOMOPATHOGENIC NEMATODE
Objective: The World Health Organization estimates that about 8 to 10 million new Tuberculosis (TB) cases occur annually worldwide and its incidence is currently increasing. There are two million deaths from TB each year. The global threat of tuberculosis demands the search for alternative antimycobacterial drugs.Â The aim of the present study was to determine the antimycobacterial activity of nine crude extracts from a Bacillus sp. N strain associated with entomopathogenic nematode Rhabditis (Oscheius) sp.
Methods: The liquid media for fermentation was prepared in TSB alone, LB alone and TSB + LB (1:1) supplemented with six different carbon sources (fructose, maltose, dextrose, mannitol, sucrose and lactose) and after fermentation crude extract was extracted using ethyl acetate. The minimum inhibitory concentration (MIC) of extracts was determined using the broth dilution method on middle brook 7H11 against M. tuberculosis H37Rv. The cytotoxicity of the extracts was determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay against VERO cell line.
Results: Out of nine extract tested only two recorded activity and significant activity was recorded by TSB+LB+lactose, followed by TSB+LB+fructose. These two extracts were nontoxic to the normal cell line.
Conclusion: Purification of these extract will get pure compounds with antimycobacterial activity in future.
2. Thaiss WM, Thaiss CC, Thaiss CA. Recent developments in the epidemiology and management of tuberculosis â€“new solutions to old problems?. Infect Drug Resist 2012;5:1â€“8.
3. Robles-Zepeda RE, Coronado-Aceves EW, VelÃ¡zquez-Contreras CA, Ruiz-Bustos E, Navarro-Navarro M, Garibay-Escobar A. In vitro anti-mycobacterial activity of nine medicinal plants used by ethnic groups in Sonora, Mexico. J BMC Complementary and Alternative Medicine 2013;3(329):1-6.
4. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wyne BA. Incidence of Mycobacterium complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992;165:1082-5.
5. Griffith D, Kerr C. Tuberculosis:disease of the past, disease of the present. J Perianesth Nurs 1996;11:240-5.
6. Chandrasekhar B, Duraipandiyan V, Al-Dhabi NA, Balakrishna K, Kalia NP, Rajput VS, Khan IA, Ignacimuthu S, Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit Indian J Microbiol 2012;52(4):676â€“81.
7. Burnell AM, Stock SP, Heterorhabditis, Steinernema and their bacterial symbionts-lethal pathogens of insects. J Nematol 2000;2:31-42.
8. Forst S, Nealson KH, Molecular Biology of the symbiotic-pathogenic bacteria Xenorhabdus spp. and Photorhabdus spp. J Microbiol 1996;51:47-57.
9. CLSI, Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically;approved standard-ninth edition. CLSI documents M07-A9. West Valley Road, Suite 2500, Wayne, PA 19087, USA, 2012a.
10. CLSI, Clinical and Laboratory Standards Institute, Performance standards for antimicrobial disk susceptibility tests;approved standard-eleventh edition. CLSI documents M02-A11. West Valley Road, Suite 2500, Wayne, PA 19087, USA, 2012b.
11. Anto RJ, Venkataraman M, Karunagaran D. Inhibition of NF-KB Sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance. J Biol Chem 2003;28:25490-8.
12. Newman DJ, Cragg GM. Natural Products as Sources of New Drugs over the last 25 years. J Nat Prod 2007;70(3):461-47.
13. Pauli GF,ï€ Case RJ, Inui T, Wang Y, Cho S, Fischer NH, Franzblau SG. New perspectives on natural products in TB drug research. J Life Sci 2005;78(5):485-94.